Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Role of the GH-IGF1 system in progression of cancer
Haim Werner
*
, Zvi Laron
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
Schneider Childrens Medical Center Israel
Research output
:
Contribution to journal
›
Review article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of the GH-IGF1 system in progression of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Growth Factors
100%
Insulin-like
100%
Growth Hormone
100%
Growth Hormone Treatment
37%
Cancer Development
25%
Oncogene
25%
Signaling Pathway
12%
Pharmacological Intervention
12%
Viral
12%
Mechanism of Action
12%
Oncology
12%
Transformed Cells
12%
In Cancer
12%
Endocrine Axis
12%
Malignant Transformation
12%
Breast Cancer Susceptibility Gene 1 (BRCA1)
12%
Cancer Risk
12%
Tumor Protein p53 (TP53)
12%
Cancer Genes
12%
Oncogenic Factor
12%
Translational Relevance
12%
Universal Mechanism
12%
Pharmacological Dose
12%
Causal Linkages
12%
Medicine and Dentistry
Malignant Neoplasm
100%
Growth Hormone
100%
Somatomedin C
100%
Endocrine Therapy
33%
Oncology
11%
Malignant Transformation
11%
BRCA1
11%
Gene Linkage
11%
Carcinogenesis
11%
Protein P53
11%
Oncogene
11%
Transformed Cell
11%
Cell Cycle
11%
Cancer Risk
11%
Virus Oncogene
11%
Cell Oncogene
11%
Carcinogen
11%
Cell Signaling Pathway
11%
Tumor Suppressor Protein
11%
Biochemistry, Genetics and Molecular Biology
Insulin-Like Growth Factor 1
100%
Bovine Somatotropin
100%
Growth Hormone
100%
Carcinogenesis
22%
Oncogene
22%
Gene Linkage
11%
Tumor Suppressor Protein
11%
Cell Cycle
11%
P53
11%
Malignant Transformation
11%
BRCA1
11%
Cell Oncogene
11%
Virus Oncogene
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Somatomedin C
100%
Growth Hormone
100%
Endocrine Therapy
33%
Carcinogen
11%
Protein P53
11%
Carcinogenesis
11%
Malignant Transformation
11%
Tumor Suppressor Protein
11%
Immunology and Microbiology
Somatomedin C
100%
Oncogene
25%
Cell Cycle
12%
Transformed Cell
12%
P53
12%
Cell Oncogene
12%
Virus Oncogene
12%